Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial.
Saved in:
| Title: | Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial. |
|---|---|
| Authors: | Nicholls SJ; Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia. stephen.nicholls@monash.edu., Ray KK; Imperial College London, London, UK., Lincoff AM; Cleveland Clinic, Cleveland, OH, USA., Sarnes E; Esperion Therapeutics, Ann Arbor, MI, USA., Gillard KK; Esperion Therapeutics, Ann Arbor, MI, USA., Bloedon L; Esperion Therapeutics, Ann Arbor, MI, USA., Migliaccio-Walle K; Curta Inc., Seattle, WA, USA., Elsea D; Curta Inc., Seattle, WA, USA., Nissen SE; Cleveland Clinic, Cleveland, OH, USA. |
| Source: | American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 Jan; Vol. 26 (1), pp. 59-70. Date of Electronic Publication: 2025 Aug 20. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40833562 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nicholls+SJ%22">Nicholls SJ</searchLink>; Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia. stephen.nicholls@monash.edu.<br /><searchLink fieldCode="AU" term="%22Ray+KK%22">Ray KK</searchLink>; Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lincoff+AM%22">Lincoff AM</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Sarnes+E%22">Sarnes E</searchLink>; Esperion Therapeutics, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Gillard+KK%22">Gillard KK</searchLink>; Esperion Therapeutics, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Bloedon+L%22">Bloedon L</searchLink>; Esperion Therapeutics, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Migliaccio-Walle+K%22">Migliaccio-Walle K</searchLink>; Curta Inc., Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Elsea+D%22">Elsea D</searchLink>; Curta Inc., Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Nissen+SE%22">Nissen SE</searchLink>; Cleveland Clinic, Cleveland, OH, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967755%22">American journal of cardiovascular drugs : drugs, devices, and other interventions</searchLink> [Am J Cardiovasc Drugs] 2026 Jan; Vol. 26 (1), pp. 59-70. <i>Date of Electronic Publication: </i>2025 Aug 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100967755 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-187X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211753277%22">11753277 </searchLink><i>NLM ISO Abbreviation: </i>Am J Cardiovasc Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40833562 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40256-025-00753-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 59 Titles: – TitleFull: Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nicholls SJ – PersonEntity: Name: NameFull: Ray KK – PersonEntity: Name: NameFull: Lincoff AM – PersonEntity: Name: NameFull: Sarnes E – PersonEntity: Name: NameFull: Gillard KK – PersonEntity: Name: NameFull: Bloedon L – PersonEntity: Name: NameFull: Migliaccio-Walle K – PersonEntity: Name: NameFull: Elsea D – PersonEntity: Name: NameFull: Nissen SE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-187X Numbering: – Type: volume Value: 26 – Type: issue Value: 1 Titles: – TitleFull: American journal of cardiovascular drugs : drugs, devices, and other interventions Type: main |
| ResultId | 1 |